Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Reaches $31.82 After 8.00% Down Move, Last Week Earthstone Energy (ESTE) Analysts

July 6, 2017 - By Adrian Mccoy

The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is a huge mover today! About 2.23M shares traded. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since July 6, 2016 and is downtrending. It has underperformed by 58.40% the S&P500.The move comes after 6 months negative chart setup for the $31.79B company. It was reported on Jul, 6 by Barchart.com. We have $29.27 PT which if reached, will make NYSE:TEVA worth $2.54 billion less.

Among 4 analysts covering Earthstone Energy (NYSE:ESTE), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Earthstone Energy had 5 analyst reports since July 21, 2015 according to SRatingsIntel. As per Wednesday, November 18, the company rating was maintained by Canaccord Genuity. See Earthstone Energy Inc (NYSE:ESTE) latest ratings:

Earthstone Energy, Inc. is an independent oil and natural gas development and production company. The company has market cap of $207.49 million. The Firm is also engaged in corporate mergers and the acquisition of oil and natural gas properties that have production and future development opportunities. It currently has negative earnings. The Company’s activities are all in the upstream segment of the oil and natural gas industry and all its properties are onshore in the United States.

About 19,141 shares traded. Earthstone Energy Inc (NYSE:ESTE) has risen 7.48% since July 6, 2016 and is uptrending. It has underperformed by 9.22% the S&P500.

Among 25 analysts covering Teva Pharma (NYSE:TEVA), 13 have Buy rating, 0 Sell and 12 Hold. Therefore 52% are positive. Teva Pharma had 60 analyst reports since July 21, 2015 according to SRatingsIntel. Guggenheim upgraded the shares of TEVA in report on Friday, December 4 to “Buy” rating. The stock has “Neutral” rating by Mizuho on Monday, October 24. The company was maintained on Monday, November 14 by RBC Capital Markets. The rating was downgraded by HSBC on Friday, November 4 to “Hold”. On Thursday, September 29 the stock rating was initiated by OTR Global with “Positive”. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) earned “Neutral” rating by Bank of America on Monday, November 7. The stock has “Buy” rating by Goldman Sachs on Monday, August 10. On Tuesday, May 3 the stock rating was maintained by Morgan Stanley with “Overweight”. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has “Buy” rating given on Monday, July 27 by Maxim Group. The firm earned “Buy” rating on Wednesday, November 16 by Maxim Group.

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The company has market cap of $31.79 billion. The Firm is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. It has a 301.18 P/E ratio. The Firm operates through two divisions: Generic medicines and Specialty medicines.